Ma Zheng-yue, Li Jun-jie, Chen Jun-tao, Tian Yun-feng, Zhang Ying-chao, Cao Yu-qing
Yao Xue Xue Bao. 2015 Jan;50(1):64-9.
The target compounds were prepared from 5-aminobenzimidazolone by two steps reaction, and their AChE inhibitory activities were measured by Ellman method in vitro. The AChE inhibitory activity of compound 4d is the best of them, and its IC50 value is equal to 7.2 μmol·L(-1), which is better than that of rivastigmine; moreover the 4d had no inhibitory activities to BuChE. Therefore, the inhibitory activities of 5-aminobenzimidazolone derivatives to acetylcholinesterase are worth further researching.
目标化合物由5-氨基苯并咪唑酮经两步反应制备,其乙酰胆碱酯酶(AChE)抑制活性通过体外Ellman法测定。化合物4d的AChE抑制活性在它们当中最佳,其半数抑制浓度(IC50)值等于7.2 μmol·L⁻¹,优于卡巴拉汀;此外,4d对丁酰胆碱酯酶(BuChE)无抑制活性。因此,5-氨基苯并咪唑酮衍生物对乙酰胆碱酯酶的抑制活性值得进一步研究。